Risk of electrolyte disorders, syncope and falls in patients taking thiazide diuretics: results of a cross-sectional study
Abstract
BACKGROUND
Thiazide diuretics are a mainstay in the management of hypertension and often associated with dyselectrolytemias. We investigated prevalence of and risk factors for hyponatremia and hypokalemia in thiazide users, substance-specific differences and the association of thiazides with syncope and falls.
METHODS
In this cross-sectional analysis all patients admitted to an interdisciplinary emergency department in Switzerland between January 1st 2017 and December 31st 2018 with measurements of serum sodium and potassium were included. Data regarding serum electrolytes and creatinine were analyzed to classify for dysnatremias, dyskalemias and acute kidney injury. Chart reviews were performed to screen for syncope or falls.
RESULTS
A total of 1,604 patients (7.9%) took thiazides. Acute kidney injury was significantly more common in thiazide users (22.1 vs. 7%, p<0.0001). Hyponatremia (22.1 vs. 9.8%, p<0.0001) and hypokalemia (19 vs. 11%, p<0.0001) were more frequent with thiazides. Thiazide use together with higher age and female sex were independent predictors of hyponatremia and hypokalemia.A dose-dependent effect was found for electrolyte disorders and there was a variance in risk between the investigated substances with chlorthalidone bearing the highest and hydrochlorothiazide the lowest risk. Patients taking thiazide diuretics had significantly more episodes of syncope and falls.
CONCLUSIONS
Thiazide use is a clear risk factor for hyponatremia and hypokalemia. The…
Read the paper
Related studies
- Sarcopenia, sarcopenic overweight/obesity and risk of cardiovascular disease and cardiac arrhythmia: A cross-sectional study
- Workplace Violence Is Associated With Impaired Work Functioning in Nurses: An Italian Cross-Sectional Study
- Vagus Nerve Dysfunction in the Post-COVID-19 Condition: a pilot cross sectional study
- Association Between Metabolic Associated Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study from NHANES 2017–2018
- Efficacy and safety of solifenacin succinate 10 mg once Daily: A multicenter, phase III, randomized, double-blind, placebo-controlled, parallel-group trial in patients with overactive bladder
- Association between triglyceride glucose‐body mass index and hypertension in Chinese adults: A cross‐sectional study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.